High expression of miR-21 and miR-155 predicts recurrence and unfavourable survival in non-small cell lung cancer

European Journal of Cancer

Volumn 49, Issue 3, 2013, Pages 604-615

  Yang, Miaomiao ^a   Shen, Hongchang ^a   Qiu, Chen ^a   Ni, Yang ^a   Wang, Liguang ^a   Dong, Wei ^a   Liao, Yida ^a   Du, Jiajun ^a  

^a SHANDONG PROVINCIAL HOSPITAL AFFILIATED TO SHANDONG UNIVERSITY   (China)

Author keywords

Lung cancer; MicroRNAs; Prognosis

Indexed keywords

MICRORNA; MICRORNA 155; MICRORNA 21;

CANCER PROGNOSIS; CANCER RECURRENCE; CANCER SPECIFIC SURVIVAL; CANCER SURVIVAL; DISEASE ASSOCIATION; HUMAN; LUNG ADENOCARCINOMA; LUNG NON SMALL CELL CANCER; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; PROTEIN EXPRESSION; RECURRENCE FREE SURVIVAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW;

EID: 84872674726     PISSN: 09598049     EISSN: 18790852     Source Type: Journal    
DOI: 10.1016/j.ejca.2012.09.031     Document Type: Article

References (61)

1. A. Jemal, R. Siegel, J. Xu, and E. Ward Cancer statistics, 2010 CA Cancer J Clin 60 5 2010 277 300
2. A. Spira, and D.S. Ettinger Multidisciplinary management of lung cancer N Engl J Med 350 4 2004 379 392
3. R.C. Lee, R.L. Feinbaum, and V. Ambros The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14 Cell 75 5 1993 843 854
4. J.G. Ruby, C. Jan, and C. Player Large-scale sequencing reveals 21U-RNAs and additional microRNAs and endogenous siRNAs in C. elegans Cell 127 6 2006 1193 1207
5. G.A. Calin, and C.M. Croce MicroRNA-cancer connection: the beginning of a new tale Cancer Res 66 15 2006 7390 7394
6. C.Z. Chen MicroRNAs as oncogenes and tumor suppressors N Engl J Med 353 17 2005 1768 1771
7. S. Mocellin, D. Hoon, A. Ambrosi, D. Nitti, and C.R. Rossi The prognostic value of circulating tumor cells in patients with melanoma: a systematic review and meta-analysis Clin Cancer Res 12 15 2006 4605 4613
8. D.F. Stroup, J.A. Berlin, and S.C. Morton Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group JAMA 283 15 2000 2008 2012
9. M.K. Parmar, V. Torri, and L. Stewart Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints Stat Med 17 24 1998 2815 2834
10. P.R. Williamson, C.T. Smith, J.L. Hutton, and A.G. Marson Aggregate data meta-analysis with time-to-event outcomes Stat Med 21 22 2002 3337 3351
11. J.F. Tierney, L.A. Stewart, D. Ghersi, S. Burdett, and M.R. Sydes Practical methods for incorporating summary time-to-event data into meta-analysis Trials 8 2007 16
12. V.S. Nair, L.S. Maeda, and J.P. Ioannidis Clinical outcome prediction by microRNAs in human cancer: a systematic review J Natl Cancer Inst 104 7 2012 528 540
13. J.A. Sterne, A.J. Sutton, and J.P. Ioannidis Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomized controlled trials BMJ 342 2011 d4002
14. W. Gao, Y. Yu, and H. Cao Deregulated expression of miR-21, miR-143 and miR-181a in non small cell lung cancer is related to clinicopathologic characteristics or patient prognosis Biomed Pharmacother 64 6 2010 399 408
15. T. Donnem, K. Eklo, and T. Berg Prognostic impact of MiR-155 in non-small cell lung cancer evaluated by in situ hybridization J Transl Med 9 2011 6
16. T. Donnem, K. Lonvik, and K. Eklo Independent and tissue-specific prognostic impact of miR-126 in nonsmall cell lung cancer: coexpression with vascular endothelial growth factor-A predicts poor survival Cancer 117 14 2011 3193 3200
17. E. Duncavage, B. Goodgame, A. Sezhiyan, R. Govindan, and J. Pfeifer Use of microRNA expression levels to predict outcomes in resected stage I non-small cell lung cancer J Thorac Oncol 5 11 2010 1755 1763
18. E. Gallardo, A. Navarro, and N. Viñolas MiR-34a as a prognostic marker of relapse in surgically resected non-small-cell lung cancer Carcinogenesis 30 11 2009 1903 1909
19. N. Yanaihara, N. Caplen, and E. Bowman Unique microRNA molecular profiles in lung cancer diagnosis and prognosis Cancer cell 9 3 2006 189 198
20. W. Zhu, X. Liu, J. He, D. Chen, Y. Hunag, and Y.K. Zhang Overexpression of members of the microRNA-183 family is a risk factor for lung cancer: a case control study BMC cancer 11 2011 393
21. Z.X. Wang, H.B. Bian, and J.R. Wang Prognostic significance of serum miRNA-21 expression in human non-small cell lung cancer J Surg Oncol 104 7 2011 847 851
22. U. Võsa, T. Vooder, and R. Kolde Identification of miR-374a as a prognostic marker for survival in patients with early-stage nonsmall cell lung cancer Genes Chromosomes Cancer 50 10 2011 812 822
23. X. Tan, W. Qin, and L. Zhang A 5-microRNA signature for lung squamous cell carcinoma diagnosis and hsa-miR-31 for prognosis Clin Cancer Res 17 21 2011 6802 6811
24. Y. Lu, R. Govindan, and L. Wang MicroRNA profiling and prediction of recurrence/relapse-free survival in stage I lung cancer Carcinogenesis 33 5 2012 1046 1054
25. S.L. Yu, H.Y. Chen, and G.C. Chang MicroRNA signature predicts survival and relapse in lung cancer Cancer cell 13 1 2008 48 57
26. S.K. Patnaik, E. Kannisto, S. Knudsen, and S. Yendamuri Evaluation of microRNA expression profiles that may predict recurrence of localized stage I non-small cell lung cancer after surgical resection Cancer Res 70 1 2010 36 45
27. -: a biomarker predictive for chemoresistance and prognostic for survival in patients with small cell lung cancer J Thorac Oncol 5 8 2010 1273 1278
28. M. Raponi, L. Dossey, and T. Jatkoe MicroRNA classifiers for predicting prognosis of squamous cell lung cancer Cancer Res 69 14 2009 5776 5783
29. M. Saito, A.J. Schetter, and S. Mollerup The association of microRNA expression with prognosis and progression in early-stage, non-small cell lung adenocarcinoma: a retrospective analysis of three cohorts Clin Cancer Res 17 7 2011 1875 1882
30. X.G. Liu, W.Y. Zhu, and Y.Y. Huang High expression of serum miR-21 and tumor miR-200c associated with poor prognosis in patients with lung cancer Med Oncol 29 2 2012 618 626
31. Z. Hu, X. Chen, and Y. Zhao Serum microRNA signatures identified in a genome-wide serum microRNA expression profiling predict survival of non-small-cell lung cancer J Clin Oncol 28 10 2010 1721 1726
32. J. Voortman, A. Goto, and J. Mendiboure MicroRNA expression and clinical outcomes in patients treated with adjuvant chemotherapy after complete resection of non-small cell lung carcinoma Cancer Res 70 21 2010 8288 8298
33. M.T. Landi, Y. Zhao, and M. Rotunno MicroRNA expression differentiates histology and predicts survival of lung cancer Clin Cancer Res 16 2 2010 430 441
34. X.C. Wang, L.L. Tian, and X.Y. Jiang The expression and function of miRNA-451 in non-small cell lung cancer Cancer Lett 311 2 2011 203 209
35. X.C. Wang, L.L. Tian, and H.L. Wu Expression of miRNA-130a in nonsmall cell lung cancer Am J Med Sci 340 5 2010 385 388
36. A. Markou, E.G. Tsaroucha, and L. Kaklamanis Prognostic value of mature microRNA-21 and microRNA-205 overexpression in non-small cell lung cancer by quantitative real-time RT-PCR Clin Chem 54 10 2008 1696 1704
37. L. Luo, T. Zhang, and H. Liu MiR-101 and Mcl-1 in non-small-cell lung cancer: expression profile and clinical significance Med Oncol 29 3 2012 1681 1686
38. J. Takamizawa, H. Konishi, and K. Yanagisawa Reduced expression of the let-7 microRNAs in human lung cancers in association with shortened postoperative survival Cancer Res 64 11 2004 3753 3756
39. N.H. Heegaard, A.J. Schetter, and J.A. Welsh Circulating micro-RNA expression profiles in early stage nonsmall cell lung cancer Int J Cancer 130 6 2012 1378 1386
40. M.R. Davidson, J.E. Larsen, and I.A. Yang MicroRNA-218 is deleted and downregulated in lung squamous cell carcinoma PLoS One 5 9 2010 e12560
41. J. Silva, V. García, and Á. Zaballos Vesicle-related microRNAs in plasma of nonsmall cell lung cancer patients and correlation with survival Eur Respir J 37 3 2011 617 623
42. J.H. Lee, J. Voortman, and A.M. Dingemans MicroRNA expression and clinical outcome of small cell lung cancer PLoS One 6 6 2011 e21300
43. Q.Z. Wang, W. Xu, N. Habib, and R. Xu Potential uses of microRNA in lung cancer diagnosis, prognosis, and therapy Curr Cancer Drug Targets 9 4 2009 572 594
44. S. Yendamuri MicroRNAs and prognosis of lung cancer Semin Thorac Cardiovasc Surg 22 4 2010 269 270
45. J. Lu, G. Getz, and E.A. Miska MicroRNA expression profiles classify human cancers Nature 435 7043 2005 834 838
46. D.F. Hayes, C. Isaacs, and V. Stearns Prognostic factors in breast cancer: current and new predictors of metastasis J Mammary Gland Biol Neoplasia 6 4 2001 375 392
47. X. Fu, Y. Han, and Y. Wu Prognostic role of microRNA-21 in various carcinomas: a systematic review and meta-analysis Eur J Clin Invest 41 11 2011 1245 1253
48. M.E. Hatley, D.M. Patrick, and M.R. Garcia Modulation of K-Ras-dependent lung tumorigenesis by MicroRNA-21 Cancer Cell 18 3 2010 282 293
49. Y. Chen, T. Knösel, and G. Kristiansen Loss of PDCD4 expression in human lung cancer correlates with tumour progression and prognosis J Pathol 200 5 2003 640 646
50. J.G. Zhang, J.J. Wang, F. Zhao, Q. Liu, K. Jiang, and G.H. Yang MicroRNA-21 (miR-21) represses tumor suppressor PTEN and promotes growth and invasion in non-small cell lung cancer (NSCLC) Clin Chim Acta 411 11-12 2010 846 852
51. S. Zhu, M.L. Si, H. Wu, and Y.Y. Mo MicroRNA-21 targets the tumor suppressor gene tropomyosin 1 (TPM1) J Biol Chem 282 19 2007 14328 14336
52. S. Fujita, T. Ito, and T. Mizutani MiR-21 Gene expression triggered by AP-1 is sustained through a double-negative feedback mechanism J Mol Biol 378 3 2008 492 504
53. G. Gabriely, T. Wurdinger, and S. Kesari MicroRNA 21 promotes glioma invasion by targeting matrix metalloproteinase regulators Mol Cell Biol 28 17 2008 5369 5380
54. S. Zhu, H. Wu, and F. Wu MicroRNA-21 targets tumor suppressor genes in invasion and metastasis Cell Res 18 3 2008 350 359
55. D. Frezzetti, M. De Menna, and P. Zoppoli Upregulation of miR-21 by Ras in vivo and its role in tumor growth Oncogene 30 3 2011 275 286
56. J. Wei, W. Gao, and C.J. Zhu Identification of plasma microRNA-21 as a biomarker for early detection and chemosensitivity of non-small cell lung cancer Chin J Cancer 30 6 2011 407 414
57. S. Jiang, H.W. Zhang, and M.H. Lu MicroRNA-155 functions as an OncomiR in breast cancer by targeting the suppressor of cytokine signaling 1 gene Cancer Res 70 8 2010 3119 3127
58. D. Ovcharenko, K. Kelnar, C. Johnson, N. Leng, and D. Brown Genome-scale microRNA and small interfering RNA screens identify small RNA modulators of TRAIL-induced apoptosis pathway Cancer Res 67 22 2007 10782 10788
59. M. Gironella, M. Seux, and M.J. Xie Tumor protein 53-induced nuclear protein 1 expression is repressed by miR-155, and its restoration inhibits pancreatic tumor development Proc Natl Acad Sci U S A 104 41 2007 16170 16175
60. W. Kong, H. Yang, and L. He MicroRNA-155 is regulated by the transforming growth factor beta/Smad pathway and contributes to epithelial cell plasticity by targeting RhoA Mol Cell Biol 28 22 2008 6773 6784
61. Y. Xi, G. Nakajima, and E. Gavin Systematic analysis of microRNA expression of RNA extracted from fresh frozen and formalin-fixed paraffin-embedded samples RNA 13 10 2007 1668 1674